Compare TLPH & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLPH | ZEPP |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.3M | 56.6M |
| IPO Year | 2010 | 2017 |
| Metric | TLPH | ZEPP |
|---|---|---|
| Price | $1.06 | $2.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.13 | N/A |
| AVG Volume (30 Days) | ★ 115.7K | 37.9K |
| Earning Date | 11-11-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,151,000.00 | N/A |
| Revenue This Year | N/A | $14.24 |
| Revenue Next Year | N/A | $6.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.69 | $2.23 |
| 52 Week High | $1.57 | $46.19 |
| Indicator | TLPH | ZEPP |
|---|---|---|
| Relative Strength Index (RSI) | 39.13 | 14.08 |
| Support Level | $1.03 | N/A |
| Resistance Level | $1.14 | $5.57 |
| Average True Range (ATR) | 0.04 | 0.27 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 27.27 | 16.67 |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.